Top ▲

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

CD80

Click here for help

Immunopharmacology Ligand target has curated data in GtoImmuPdb

Target id: 2744

Nomenclature: CD80

Family: Other immune checkpoint proteins, CD molecules

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 1 288 3q13.33 CD80 CD80 molecule
Mouse 1 306 16 26.86 cM Cd80 CD80 antigen
Rat - 321 11q21 Cd80 Cd80 molecule
Previous and Unofficial Names Click here for help
B-lymphocyte activation antigen B7 | CD28LG | CD80 antigen
Database Links Click here for help
Alphafold
CATH/Gene3D
ChEMBL Target
DrugBank Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Gene
OMIM
Pharos
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia
Immunopharmacology Comments
CD80 (B7-1) is expressed on dendritic cells and activated B cells and monocytes. It is required to provide a costimulatory signal necessary for T cell activation and survival. CD80 works in concert with CD86 to prime T cells. CD80 binds CD28 and CTLA-4 on T cells. It is the interaction with CTLA-4 that is targeted by the approved immunosuppresive drugs abatacept and belatacept.
Cell Type Associations
Immuno Cell Type:  Macrophages & monocytes
Cell Ontology Term:   macrophage (CL:0000235)
monocyte (CL:0000576)
Immuno Cell Type:  Dendritic cells
Cell Ontology Term:   dendritic cell (CL:0000451)
Immuno Cell Type:  B cells
Cell Ontology Term:   B cell (CL:0000236)
Immuno Cell Type:  T cells
Immuno Process Associations
Immuno Process:  Barrier integrity
GO Annotations:  Associated to 1 GO processes, IEA only
click arrow to show/hide IEA associations
GO:0001618 virus receptor activity IEA
Immuno Process:  B cell (activation)
GO Annotations:  Associated to 2 GO processes
GO:0002710 negative regulation of T cell mediated immunity IDA
GO:0045627 positive regulation of T-helper 1 cell differentiation NAS
Immuno Process:  Cellular signalling
GO Annotations:  Associated to 5 GO processes
GO:0031295 T cell costimulation IBA
GO:0042102 positive regulation of T cell proliferation IBA
GO:0042110 T cell activation IDA
GO:0042130 negative regulation of T cell proliferation IBA
GO:0045627 positive regulation of T-helper 1 cell differentiation NAS
Immuno Process:  Chemotaxis & migration
GO Annotations:  Associated to 4 GO processes
GO:0031295 T cell costimulation IBA
GO:0042102 positive regulation of T cell proliferation IBA
GO:0042130 negative regulation of T cell proliferation IBA
GO:0045627 positive regulation of T-helper 1 cell differentiation NAS
Immuno Process:  Cytokine production & signalling
GO Annotations:  Associated to 2 GO processes
GO:0032725 positive regulation of granulocyte macrophage colony-stimulating factor production NAS
GO:0032743 positive regulation of interleukin-2 production NAS
Immuno Process:  Immune regulation
GO Annotations:  Associated to 5 GO processes
GO:0002710 negative regulation of T cell mediated immunity IDA
GO:0031295 T cell costimulation IBA
GO:0042102 positive regulation of T cell proliferation IBA
GO:0042130 negative regulation of T cell proliferation IBA
GO:0045627 positive regulation of T-helper 1 cell differentiation NAS
Immuno Process:  Immune system development
GO Annotations:  Associated to 1 GO processes
GO:0045627 positive regulation of T-helper 1 cell differentiation NAS
Immuno Process:  Inflammation
GO Annotations:  Associated to 1 GO processes
GO:0045627 positive regulation of T-helper 1 cell differentiation NAS
Immuno Process:  T cell (activation)
GO Annotations:  Associated to 6 GO processes
GO:0002710 negative regulation of T cell mediated immunity IDA
GO:0031295 T cell costimulation IBA
GO:0042102 positive regulation of T cell proliferation IBA
GO:0042110 T cell activation IDA
GO:0042130 negative regulation of T cell proliferation IBA
GO:0045627 positive regulation of T-helper 1 cell differentiation NAS
Immuno Disease Associations
Disease Name:  Allograft rejection
Disease Synonyms:  no synonynms
Comment:  CD80 is a primary target of the approved anti-rejection drug belatacept.
Disease Name:  Rheumatoid arthritis
Disease Synonyms:  no synonynms
Comment:  CD80 is a primary target of the ligand abatacept, which is clinically approved for the treatment of rheumatoid arthritis.
Disease X-refs:  Disease Ontology: DOID:7148
OMIM: 180300
References:  3
General Comments
This protein contains an immunoglobulin (Ig)-like domain that resembles the antibody variable domain, that has been coined the 'V-set domain'. The genes for all human V-set domain containing proteins are listed in HGNC gene group 590.

References

Show »

1. Latek R, Fleener C, Lamian V, Kulbokas 3rd E, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R. (2009) Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation. Transplantation, 87 (6): 926-33. [PMID:19300198]

2. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med, 174 (3): 561-9. [PMID:1714933]

3. Vicente Rabaneda EF, Herrero-Beaumont G, Castañeda S. (2013) Update on the use of abatacept for the treatment of rheumatoid arthritis. Expert Rev Clin Immunol, 9 (7): 599-621. [PMID:23899231]

How to cite this page

Other immune checkpoint proteins: CD80. Last modified on 28/06/2022. Accessed on 18/06/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2744.